Literature DB >> 2205627

Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation.

Z Zadik1, S A Chalew, A Kowarski.   

Abstract

The integrated concentration of serum GH (IC-GH) is used for the assessment of spontaneous GH secretion. In order to use the IC-GH as a diagnostic tool a normative reference range needs to be established. We determined the IC-GH by continuous blood withdrawal in 119 children of normal height, weight and growth rate. Although the mean IC-GH increased with pubertal status, 4.4 +/- 1.2 micrograms/L at Tanner I (n = 36), 5.5 +/- 2.1 micrograms/L at Tanner II-III (n = 43), and 5.8 +/- 1.6 at Tanner IV-V (n = 40) (P less than 0.03), there was a considerable overlap of individual IC-GH levels between the pubertal groups. Gender affected the mean IC-GH level slightly, but not the range. Although the mean IC-GH of girls tended to be higher than that of boys this difference was not statistically significant. Ninety five percent of the IC-GH values were above the 3.2 micrograms/L level. The response to pharmacological stimulation (clonidine, insulin, or arginine) was also evaluated in 68 of the subjects. The peak GH response to pharmacological stimulation (micrograms/L) with clonidine 21.0 +/- 10.7 (n = 66) was significantly higher than to either arginine 13.1 +/- 6.1 (n = 23) or insulin 14.2 +/- 6.3 (n = 19) (P less than 0.01). The peak response to clonidine increased significantly with pubertal status (P less than 0.001) and there was an interactive effect of gender and pubertal stage where the GH response of prepubertal boys exceeded that of prepubertal girls but the response of pubertal girls exceeded that of pubertal boys (P less than 0.02). The peak stimulated GH levels was correlated with IC-GH in this subgroup r = 0.52, P less than 0.0001). This study provides a large normative data base for IC-GH and the GH provocative tests in normally growing children of varying pubertal status.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205627     DOI: 10.1210/jcem-71-4-932

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  More guidance on growth hormone deficiency.

Authors:  R Ayling
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

2.  Growth hormone release during insulin tolerance, clonidine, arginine and growth hormone releasing hormone tests in short normal children and adolescents.

Authors:  L Cavallo; A Acquafredda; S Liuzzi; R Russo; C Zecchino; R Leuzzi; T Giobbe; L Piacente
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

Review 3.  Diagnosis of GH deficiency: auxologic and GH response criteria.

Authors:  R J Dash; G Pathmanathan; S Prakash; J S Saini
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

4.  Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.

Authors:  J Bellone; G Aimaretti; S Bellone; C Baffoni; G Corneli; C Origlia; M Cappa; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

5.  Adding Glucagon-Stimulated GH Testing to the Diagnostic Fast Increases the Detection of GH-Sufficient Children.

Authors:  Colin P Hawkes; Adda Grimberg; Vivian E Dzata; Diva D De Leon
Journal:  Horm Res Paediatr       Date:  2016-03-17       Impact factor: 2.852

Review 6.  Diagnosis of growth hormone deficiency in childhood.

Authors:  Takara Stanley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-02       Impact factor: 3.243

7.  Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess.

Authors:  Alison M Boyce; McKinley Glover; Marilyn H Kelly; Beth A Brillante; John A Butman; Edmond J Fitzgibbon; Carmen C Brewer; Christopher K Zalewski; Carolee M Cutler Peck; H Jeffrey Kim; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2012-10-23       Impact factor: 5.958

8.  Short procedure of GHRH plus arginine test in clinical practice.

Authors:  G Aimaretti; S Bellone; C Baffoni; G Cornel; C Origlia; L Di Vito; S Rovere; E Arvat; F Camanni; E Ghigo
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

9.  Growth hormone response to oral clonidine test in normal and short children.

Authors:  S Loche; M Cappa; E Ghigo; A Faedda; A Lampis; D Carta; C Pintor
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 10.  Provocative growth hormone testing in children: how did we get here and where do we go now?

Authors:  Camilia Kamoun; Colin Patrick Hawkes; Adda Grimberg
Journal:  J Pediatr Endocrinol Metab       Date:  2021-04-12       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.